Systematic reviews and meta-analysis with sub-groups: A commentary

Monica Peddle; Fatimah Alenazi; Richard Gray; Daniel Bressington

doi:10.1016/j.sapharm.2023.09.007

Systematic reviews and meta-analysis with sub-groups: A commentary

Monica Peddle, Fatimah Alenazi, Richard Gray, Daniel Bressington

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

As the outcomes of systematic reviews and meta-analysis are used to inform clinical practice it is imperative that the review and meta-analysis conducted is accurate and rigorous. In this commentary the authors wish to review the recommended approaches to be used when conducting a meta-analysis of quantitative data in a systematic review and outline the common errors and risks. The authors of this commentary aim to highlight the consequence of potential errors when conducting a meta-analysis using sub-groups with an example from a systematic review published in Research in Social and Administrative Pharmacy in 2019.

Original language	English
Pages (from-to)	63-65
Number of pages	3
Journal	Research in Social and Administrative Pharmacy
Volume	20
Issue number	1
Early online date	26 Sept 2023
DOIs	https://doi.org/10.1016/j.sapharm.2023.09.007
Publication status	Published - Jan 2024

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.sapharm.2023.09.007

Cite this

@article{362d3879dac9432fb4206e8466d391a9,

title = "Systematic reviews and meta-analysis with sub-groups: A commentary",

abstract = "As the outcomes of systematic reviews and meta-analysis are used to inform clinical practice it is imperative that the review and meta-analysis conducted is accurate and rigorous. In this commentary the authors wish to review the recommended approaches to be used when conducting a meta-analysis of quantitative data in a systematic review and outline the common errors and risks. The authors of this commentary aim to highlight the consequence of potential errors when conducting a meta-analysis using sub-groups with an example from a systematic review published in Research in Social and Administrative Pharmacy in 2019.",

keywords = "Diabetes, Meta-analysis, Systematic review, Type 2 diabetes",

author = "Monica Peddle and Fatimah Alenazi and Richard Gray and Daniel Bressington",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2024",

month = jan,

doi = "10.1016/j.sapharm.2023.09.007",

language = "English",

volume = "20",

pages = "63--65",

journal = "Research in Social and Administrative Pharmacy",

issn = "1551-7411",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Systematic reviews and meta-analysis with sub-groups

T2 - A commentary

AU - Peddle, Monica

AU - Alenazi, Fatimah

AU - Gray, Richard

AU - Bressington, Daniel

PY - 2024/1

Y1 - 2024/1

N2 - As the outcomes of systematic reviews and meta-analysis are used to inform clinical practice it is imperative that the review and meta-analysis conducted is accurate and rigorous. In this commentary the authors wish to review the recommended approaches to be used when conducting a meta-analysis of quantitative data in a systematic review and outline the common errors and risks. The authors of this commentary aim to highlight the consequence of potential errors when conducting a meta-analysis using sub-groups with an example from a systematic review published in Research in Social and Administrative Pharmacy in 2019.

AB - As the outcomes of systematic reviews and meta-analysis are used to inform clinical practice it is imperative that the review and meta-analysis conducted is accurate and rigorous. In this commentary the authors wish to review the recommended approaches to be used when conducting a meta-analysis of quantitative data in a systematic review and outline the common errors and risks. The authors of this commentary aim to highlight the consequence of potential errors when conducting a meta-analysis using sub-groups with an example from a systematic review published in Research in Social and Administrative Pharmacy in 2019.

KW - Diabetes

KW - Meta-analysis

KW - Systematic review

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85173816365&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2023.09.007

DO - 10.1016/j.sapharm.2023.09.007

M3 - Comment/debate

AN - SCOPUS:85173816365

SN - 1551-7411

VL - 20

SP - 63

EP - 65

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

IS - 1

ER -

Systematic reviews and meta-analysis with sub-groups: A commentary

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this